PSMD12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.531000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.459200E-01
Normal-vs-Stage2
4.571000E-01
Normal-vs-Stage3
7.234400E-01
Normal-vs-Stage4
2.637200E-01
Stage1-vs-Stage2
4.856600E-01
Stage1-vs-Stage3
8.405600E-01
Stage1-vs-Stage4
3.005000E-01
Stage2-vs-Stage3
7.391400E-01
Stage2-vs-Stage4
6.158200E-01
Stage3-vs-Stage4
5.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.754600E-01
Normal-vs-AfricanAmerican
2.289400E-01
Normal-vs-Asian
5.810200E-01
Caucasian-vs-AfricanAmerican
2.913800E-01
Caucasian-vs-Asian
9.796600E-01
AfricanAmerican-vs-Asian
4.826400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.481800E-01
Normal-vs-Female
3.362400E-01
Male-vs-Female
2.772200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.000000E-01
Normal-vs-Age(41-60Yrs)
2.086600E-01
Normal-vs-Age(61-80Yrs)
6.225600E-01
Normal-vs-Age(81-100Yrs)
6.471600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.414000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.108000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.340000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.013300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.550400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.533800E-01
Normal-vs-Daily Drinker
9.638800E-01
Normal-vs-Weekly Drinker
5.960800E-01
Normal-vs-Occasional Drinker
3.529600E-01
Normal-vs-Social Drinker
1.331440E-01
Non Drinker-vs-Daily Drinker
3.571400E-01
Non Drinker-vs-Weekly Drinker
8.843200E-01
Non Drinker-vs-Occasional Drinker
2.332200E-01
Non Drinker-vs-Social Drinker
2.870200E-01
Daily Drinker-vs-Weekly Drinker
3.418000E-01
Daily Drinker-vs-Occasional Drinker
5.204100E-02
Daily Drinker-vs-Social Drinker
4.918000E-02
Weekly Drinker-vs-Occasional Drinker
3.871200E-01
Weekly Drinker-vs-Social Drinker
4.980600E-01
Occasional Drinker-vs-Social Drinker
6.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.334000E-01
Normal-vs-Grade 2
9.928600E-01
Normal-vs-Grade 3
9.179600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.773440E-01
Grade 1-vs-Grade 3
2.605800E-02
Grade 1-vs-Grade 4
9.334000E-01
Grade 2-vs-Grade 3
1.204570E-01
Grade 2-vs-Grade 4
9.928600E-01
Grade 3-vs-Grade 4
9.179600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.554200E-01
Normal-vs-NonDiabetic
4.594800E-01
Diabetic-vs-NonDiabetic
5.632500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.586800E-01
Normal-vs-NoPancreatitis
5.281600E-01
Pancreatitis-vs-NoPancreatitis
6.641600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.110200E-01
Normal-vs-N1
4.541000E-01
N0-vs-N1
7.340600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.705400E-01
Normal-vs-TP53-NonMutant
7.104200E-01
TP53-Mutant-vs-TP53-NonMutant
3.436900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
